Purpose: The aim of this study was to present a case of a Baerveldt glaucoma implant lumen being completely occluded with a 3-0 Supramid stent suture.
CASE REPORT
Glaucoma drainage devices (GDDs) are composed of a silicone tube (∼0.3 mm inner diameter) connected to a plate that drains aqueous humor from the anterior chamber to the subconjunctival space. GDDs can be valved to restrict flow below certain levels of IOP, such as the Ahmed glaucoma valve (New World Medical, Rancho Cucamonga, CA), or nonvalved such as the 350 mm 2 Baerveldt glaucoma implant (BGI) (Abbott Medical Optics, Santa Ana, CA). Studies have shown that the BGI has comparable outcomes to glaucoma filtration surgery. 1 The BGI requires the use of a stent suture inserted within or around the tube lumen to restrict flow initially following device insertion that is often removed several months later. It is our standard practice to place a 3-0 Supramid Extra suture (0.2 to 0.249 mm diameter) (S. Jackson, Alexandria, VA), a cable-type multifilament suture coextruded from nylon 6 and nylon 6.6, within the tube. 2, 3 While we have demonstrated that the suture acts to reduce the risk of early hypotony, 2 the suture diameter should be sufficiently small to allow some aqueous flow through the silicone tube to the subconjunctival plate. We report a case of intraoperative BGI device failure due to complete lumen occlusion with the Supramid stent suture that we validated using an in vitro microfluidic flow assessment setup following removal of the device.
Intraoperatively, the Supramid suture was inserted into the tube lumen and the plate subsequently sutured to the sclera. Before the tube was inserted into the anterior chamber, we assessed the patency of the device as per our standard practice by irrigation using balanced salt solution through a 27-G Rycroft cannula passed into the end of the tube lumen. Whereas we would expect balanced salt solution to flow from the tube to the plate (past the suture within the lumen), instead the silicone tube ballooned significantly (Fig. 1A) and no flow was observed. The phenomenon repeatedly occurred despite 3 different batches of the suture being placed within the lumen. The device subsequently had to be removed from the sclera and replaced with another device that did not suffer from the same issue.
Subsequent in vitro microfluidic assessment of the nonfunctioning BGI, consisting of a reservoir of water connected to a microfluidic pressure pump/flow sensor (Fluigent, Villejuif, France), was performed. We were not able to generate flow through the BGI tube when any length of Supramid suture was placed in the tube up to connection with the plate despite the presence of > 150 mm Hg of downward pressure. When excessive pressure was exerted on the nonfunctioning implant, the silicone tube ballooned as per Figure 1A without aqueous flow to the plate. Figure 1B shows the Supramid suture sitting within the tube lumen with thinning of the tube wall at the site of ballooning. Figure 1C shows the external orifice where the tube enters the plate and was measured as 300 μm wide. Figure 1D , therefore, demonstrates the location that we believe is where the manufacturing defect of the implant has occurred (the insertion of the tube into the plate) that prevented aqueous flow through the tube lumen following placement of the Supramid suture.
We report a case where the device failed flow-testing assessment before tube insertion into the anterior chamber and subsequently the whole device had to be removed and replaced. Repeated suturing of the sclera risks complications such as scleral perforation. As far as the authors are aware, this is the first time that such BGI failure has been reported in the literature and we highlight a manufacturing defect of both the tube wall and connection between the tube and the plate in this case. We wish to increase the awareness of performing a flow-testing assessment of BGI devices intraoperatively following placement of a stent suture in the tube lumen and before insertion into the eye to minimize the risk of intraoperative and/or postoperative complications.
